Pharmacotherapy for atrial arrhythmias: present and future.

  title={Pharmacotherapy for atrial arrhythmias: present and future.},
  author={Michael J Mazzini and Kevin M. Monahan},
  journal={Heart rhythm},
  volume={5 6 Suppl},
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice. It is associated with significant morbidity, including palpitations, exercise intolerance, congestive heart failure, and increased risk of embolic stroke. Mortality is increased twofold in patients with AF. Management of AF with antiarrhythmic drugs traditionally has been hindered by lack of efficacy, poor tolerance of side effects, drug-associated toxicity, and proarrhythmic potential. Improved… CONTINUE READING


Publications citing this paper.
Showing 1-7 of 7 extracted citations

New pharmacological strategies for the treatment of atrial fibrillation.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc • 2009

Similar Papers

Loading similar papers…